Securitisation: reducing risk and accounting volatility IFRS 9 and significant risk transfer

Similar documents
Risk and Accounting. IFRS 9 Financial Instruments. Marco Venuti 2018

Need to know. FRC publishes Triennial review 2017 Incremental improvements and clarifications (Amendments to FRS 102) Contents

First Impressions: IFRS 9 Financial Instruments

IFRS News. Special Edition on IFRS 9 (2014) IFRS 9 Financial Instruments is now complete

Overview Why the introduction of IFRS 9?

The proposed solution to the de-coupling of IFRS 9 and IFRS 4 Phase II

IFRS industry insights

STS easy as STC, easy as 1, 2, 3. Or is it? Operational efforts to revive the securitisation market

Acumen Conference IFRS 9 for insurers

IAS 39 the sequel. Time for new measures. August Background

Applying IFRS 9 Part II (Discussion) Presentation by: CPA Stephen Obock February 2018

Technically Speaking The Light of Knowledge. Accounting & Auditing 21st Edition April 2016

IFRS 9 Impairment Requirements

IFRS 9 Classification and Measurement Presentation by: CPA Stephen Obock March 2018

Get ready for FRS 109: Classifying and measuring financial instruments. July 2018

The biotech IPO landscape

Nationwide Building Society Report on Transition to IFRS 9

Putting IFRS 9 into practice Presentation by: CPA Stephen Obock February 2018

Another step closer to finalising IFRS 4 Phase II More education on participating contracts while IFRS 9 is issued in final text

Significant Risk Transfer in Securitisation. Public Hearing, EBA premises, 17 November 2017

Consultation Paper. Draft Guidelines On Significant Credit Risk Transfer relating to Article 243 and Article 244 of Regulation 575/2013

IAS 32 & IFRS 9 Financial Instruments

AL AHLI BANK OF KUWAIT K.S.C.P. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED FINANCIAL INFORMATION (UNAUDITED) 30 SEPTEMBER 2018

New and revised Standards -Applying IFRS 9 Presentation by: CPA Stephen Obock December 2017

IFRS 9 for Insurers. Syysseminaari. Aktuaaritoiminnan kehittämissäätiö. 30 November 2017

Sir David Tweedie Chairman International Accounting Standards Board 30 Cannon Street London. United Kingdom EC4M 6XH.

Consolidated Financial Statements

Interim Condensed Consolidated Financial Statements

IFRS 9: A silent revolution in banks business models

Arab Banking Corporation (B.S.C.)

In depth IFRS 9: Expected credit losses August 2014

How is IFRS9 expected to impact capital adequacy ratios of Maltese banks? Deloitte Malta Risk Advisory - Banking

AL AHLI BANK OF KUWAIT K.S.C.P. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED FINANCIAL INFORMATION (UNAUDITED) 31 MARCH 2018

Financial Instruments. October 2015 Slide 2

EMIRATES NBD BANK PJSC

BANK ALJAZIRA (A Saudi Joint Stock Company)

CRR IV - Article 194 CRR IV Principles governing the eligibility of credit risk mitigation techniques legal opinion

Alexander Marianski August IFRS 9: Probably Weighted and Biased?

A sea of change in new IFRS Standards Impact on the shipping industry

IFRS 9 Financial Instruments : Transition. Lloyds Banking Group plc

Implementing IFRS 9: a guide for lessors

Arab Banking Corporation (B.S.C.)

IFRS 9 Disclosure Checklist

IFRS 9 The final standard

Classification of financial instruments under IFRS 9

IFRS 9 financial instruments transition report as at 1 July

IASB finalises IFRS 9 which changes the classification and measurement of financial assets and introduces an expected loss impairment model

In depth IFRS 9 Impact on the Pharmaceutical Industry December 2017 No. INT

IFRS 9 FINANCIAL INSTRUMENTS

FRS 109 Financial Instruments

GUIDELINES ON SIGNIFICANT RISK TRANSFER FOR SECURITISATION EBA/GL/2014/05. 7 July Guidelines

Investec plc silo IFRS 9 Financial Instruments Transition Report

The Bank of Nevis Limited

CREDIT BANK OF MOSCOW (public joint-stock company)

Navigating the changes to New Zealand Equivalents to International Financial Reporting Standards

IFRS 9 FINANCIAL INSTRUMENTS FOR NON FINANCIAL INSTITUTIONS. New member firm training 2010 Page 1

IFRS 9 Readiness for Credit Unions

EMIRATES NBD BANK PJSC

FINANCIAL REPORTING WORKSHOP **IFRS 9: FINANCIAL INSTRUMENTS** Presentation by: CPA Boniface L Souza, ACIM, CFIP Wednesday, 15 th November 2017

In Depth Treasury and securities portfolios: practical implications of IFRS 9 classification and measurement December 2017

Applying IFRS. IFRS 9 for non-financial entities. March 2016

AHLI UNITED BANK K.S.C.P. KUWAIT INTERIM CONDENSED CONSOLIDATED FINANCIAL INFORMATION 30 JUNE 2018 (UNAUDITED)

Close Brothers Group plc T +44 (0) Crown Place E Close Brothers Group plc. IFRS 9 Transition Report

Transition to IFRS 9

AHLI UNITED BANK K.S.C.P. KUWAIT INTERIM CONDENSED CONSOLIDATED FINANCIAL INFORMATION 31 MARCH 2018 (UNAUDITED)

CREDIT BANK OF MOSCOW (public joint-stock company)

An Overview of the Impairment Requirements of IFRS 9 Financial Instruments

IFRS 15. Revenue from Contracts with Customers

EMIRATES NBD BANK PJSC

Contents. Financial instruments the complete standard. Fundamental changes call for careful planning. 1. Overview Complete IFRS 9

Nottingham Building Society. Pillar 3 Disclosures

IFRS industry insights

ICG ANNUAL REPORT & ACCOUNTS 2017 GOVERNANCE REPORT STATEMENTS

Applying IFRS. IFRS 12 Example disclosures for interests in unconsolidated structured entities

QAU. Alert IN THIS ISSUE. Issue No

SEB Group IFRS 15 and IFRS 9 transition disclosures Summary of transition disclosure

THE SAUDI INVESTMENT BANK (A Saudi joint stock company)

LENDINVEST SECURED INCOME PLC. Interim unaudited report for the 6 month period ended 30 September Company registration number:

Investec Limited group IFRS 9 Financial Instruments Transition Report

IFRS Project Insights Financial Instruments: Classification and Measurement

Brexit The vote to leave key considerations for half year reporting

Financial instruments IFRS 9 development Project phase Exposure draft Status / next steps 1a. Classification & measurement of financial assets 1b. Cla

Acumen Financial Institutions Accounting and Reporting. IFRS 9 Financial Instruments Classification 9 June 2015

EBA REPORT ON RESULTS FROM THE SECOND EBA IMPACT ASSESSMENT OF IFRS July 2017

27 July International Accounting Standards Board 30 Cannon Street, London EC4M BXH. United Kingdom. Dear Madam, dear Sir,

JNFM MUTUAL FUNDS LIMITED - LOCAL MONEY MARKET FUND FINANCIAL STATEMENTS

The Bank of Nevis Limited

Opinion of the European Banking Authority on transitional arrangements and credit risk adjustments due to the introduction of IFRS 9

Consultative Document - Guidance on accounting for expected credit losses

Deutsche Bank. IFRS 9 Transition Report

NALCOR ENERGY MARKETING CORPORATION FINANCIAL STATEMENTS December 31, 2018

Commercial Bank International P.S.C. Reports and the consolidated financial statements for the year ended 31 December 2017

Re: Exposure Draft, Investments in Debt Instruments - proposed amendments to IFRS 7

pwc.com/ifrs In depth New IFRSs for 2017

QNB FINANCE LTD CONDENSED INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 JUNE 2018

Tax Strategy for The Bahamas as an IFC 2 March 2018

Olivier Guersent Director General, Financial Stability, Financial Services and Capital Markets Union European Commission 1049 Brussels

IFRS 9 Financial Instruments. IICPAK: The Financial Reporting Workshop 4 th and 5 th December 2014 Hilton Hotel, Nairobi

Welcome to the participants of ICAI- Dubai Chapter on IFRS 9 Presentation

Gedeon Richter Consolidated Financial Statements 2014

Transcription:

Securitisation: reducing risk and accounting volatility IFRS 9 and significant risk transfer

Originally published: May 2018

Contents Executive summary 1 Impact of IFRS 9 on Banks 2 Mitigating IFRS 9 volatility with securitisation 3 Reducing regulatory capital requirements via securitisation 4 Reducing leverage through accounting de-recognition 5 Next steps 6 Contacts 7 Other papers in the securitisation series 7

Executive summary The introduction of IFRS 9 1 for European banks hasn t had as severe an impact on banks capital ratios as was initially feared by many analysts. This can be principally attributed to its introduction at a benign point in the economic cycle, which along with central banks quantitative easing has led to loans performing well over recent years. As the global economy enters a rising interest rate environment as a consequence of changes in the economic cycle, the good loan performance observed in recent years may deteriorate. The pro-cyclical effects of IFRS 9 in future downturns has the potential to trigger significant increases in provisioning, which will directly result in greater P&L volatility and lower capital ratios for banks. For certain credit portfolios on banks balance sheets this may become an acute problem, both in terms of P&L impact and level of regulatory capital required. This paper highlights one possible solution to this; properly structured securitisation transactions present an opportunity to mitigate IFRS 9 loan loss provisions, with the potential to result in: Reduction of P&L volatility arising from the loan loss provisions Reduction in risk weighted assets by achieving regulatory capital relief via significant risk transfer Full / partial de-recognition of assets from a bank s balance sheet On their own any of these three outcomes are potentially attractive, together they become even more compelling. This paper outlines how this might be achieved and some of the considerations required. Properly structured securitisation transactions present an opportunity to mitigate IFRS 9 loan loss provisions. 1. IFRS 9 Financial Instruments 1

Impact of IFRS 9 on Banks Background to IFRS 9 In the wake of criticism of the IAS 39 2 cliff edge approach to loan loss provisions, one of the desired effects of IFRS 9 was to make accounting provisions more proactive and forward looking. This was principally achieved by requiring accounting provisions to be based on an expected loss recognition model rather than one of incurred losses, thereby resulting in accounting provisions typically being recognised earlier in the credit cycle than previously under IAS 39. Importantly, the overall loss recognised over the life of the loan under IFRS 9 will be the same as that under its predecessor IAS 39. Classification of loans under IFRS 9 Under IFRS 9 debt instruments are classified in one of three categories, amortised cost, fair value through other comprehensive income (FVTOCI), and fair value through profit and loss (FVTPL). This classification is dependent on whether the cash flows are solely payments of principal and interest (SPPI) as well as the entity s business model for holding the assets. A significant increase in credit risk is what prompts the change in classification from Stage 1 to Stage 2 and is therefore what triggers the requirement for increased provisions. However, it is the ability for loans to move between stages and the forward looking nature of the model which creates scope for significant volatility in the provisioning as illustrated below. From Impairment Stage To 1 2 3 Written off 1 X 1 X 2 X 3 X 4 2 Y 1 Y 2 Y 3 Y 4 Business model Hold to collect Hold to collect and sell Neither of the above SPPI qualifying cash flows? Yes Classification basis Amortised cost Expected Credit Losses (ECL) relevant? Yes No FVTPL No Yes FVOCI Yes NO FVTPL No N/A FVTPL No Provisioning under IFRS 9 For the majority of banks their credit portfolios are held at amortised cost, meaning they are recorded at cost plus/minus accumulated amortisation less any provisions. The general IFRS 9 impairment model categorises loan performance into three distinct stages which effect the level of provisions required. 3 Z 2 Z 3 Z 4 Impairment basis X i, Y i, Z i staging migration probabilities The impairment movement from Stage 1 to Stage 2 and vice versa creates P&L volatility that is new to banks. This crystallises contingent risk on the balance sheet of regulated banks, introducing volatility to regulatory capital. The level of volatility will be amplified under stress. Effect of IFRS 9 on banks As most credit portfolios are held at amortised cost the immediate consequence of this change from incurred to expected losses is an increase in provisions over the short to medium term. However, given the benign economic environment post crisis, the impact to date has not been as significant as had been initially expected. However, this may change with the economic cycle. Z 1 12 month Lifetime Written off The impairment movement from Stage 1 to Stage 2 and vice versa creates P&L volatility that is new to banks. Stage Status Provision required 1 Performing 12 month ECL 2 Significant increase in credit risk Lifetime ECL 3 Credit event has occurred Lifetime ECL 2. IAS 39 Financial Instruments 2

Mitigating IFRS 9 volatility with securitisation Some of the most profitable credit portfolios for banks to hold may also be the most volatile from an accounting perspective. While the financial returns are attractive, a bank may also find it attractive to mitigate this IFRS 9 volatility. One way of doing this is potentially via synthetic securitisation, where a segment of the portfolios risk is transferred to investors. The diagram below provides an illustrative example of a synthetic securitisation which may be able to achieve this. Transaction A Borrower Loan Repayments Loan Repayments Risk Transfer Agreement executed through credit default swaps Lending Bank Protection premium Credit loss protection Cash released to cover losses on reference portfolio Securitisation SPV GIC Provider Combination of CDS and CLN execution Cash Proceeds from CLN sold to Hedge Fund Core Stage 1 (CS1) Volatility Mitigating Tranche (VMT) Core Stage 2 (CS2) Stage 3 (S3) CDS based protection CDS or CLN Issuance CDS or CLN Issuance CDS Credit Default Swap CLN Credit Linked Note GIC Guaranteed Investment Contract Lending Bank External Investors Either retained by originator or distributed to investors How would Transaction A work? Synthetic securitisation works by using credit derivatives to provide protection against credit losses on a reference portfolio of assets. In order to achieve this the derivative(s) are structured in such a way that their value changes relative to the provisions. This means the credit derivative provides an asset to mitigate the expected losses of the protected segment thus reducing the P&L impact of the provisions. In this particular example the portfolio has been tranched on the basis of the IFRS 9 stages, with attachment points based on probabilities of migration rather than traditional levels of credit enhancement, and a volatility mitigating tranche has been created to capture the segment of the portfolio which will fluctuate between Stage 1 and Stage 2. The VMT mitigates the volatility arising from ECLs such that a P&L gain is recognised if there is an increase in ECL. Such an increase could occur if there is a change in assets from Stage 1 to Stage 2. Generally, a P&L gain will be recognised to the extent that the ECL on the reference assets will ultimately be reimbursed by the structure thereby providing a degree of P&L offset. The release of cash by the VMT provides the necessary collateral for credit mitigation purposes. Credit derivatives and insurance contracts One drawback to using derivatives is that they need to be fair valued, which potentially introduces a different source of volatility. One of the concepts that underpins accounting is that of substance over form, which requires one to look past legal form and examine the substance of transactions and core definitions for the purposes of accounting classification. It follows that a credit protection instrument that takes the legal form of a derivative may meet the accounting definition of an insurance contract. Under IFRS, insurance contracts held are not fair valued and instead policy holders recognise gains when they are virtually certain to be received under the terms of the contract thereby avoiding derivative volatility. 3

Reducing regulatory capital requirements via securitisation In addition to reducing a bank s P&L volatility through an IFRS 9 hedging transaction, if structured correctly, the same transaction could simultaneously also be used to reduce a bank s regulatory capital requirements via significant risk transfer (SRT). Regulatory Requirements In order to achieve significant risk transfer a bank needs to meet the criteria set out in CRR 3 Articles 243 and 244. The most straightforward of these are the quantitative tests which are outlined in the box opposite. While the quantitative tests are generally well understood by most participants in the European SRT market, what is now receiving increased focus is regulatory scrutiny around commensurate risk transfer. The short passage in the CRR on commensurate risk transfer was considered fairly innocuous by most, and few NCAs placed emphasis on, but it is now being given renewed prominence by other European bodies such as the EBA, who in their September 2017 paper 4 made suggestions regarding how commensurateness might be assessed in a standardised fashion across European banks. This raises the prospect of greater application of a commensurateness test across the EU. Commensurate Risk Transfer In its simplest terms, commensurate risk transfer aims to assess the transfer of risk versus the transfer of RWEAs that the selling bank is trying to achieve. Mathematically this might be expressed as Pre Post % change in measure Risk Measure a 1 a 2 α = (a 1 a 2 )/a 1 RWEA b 1 b 2 β = (b 1 b 2 )/b 1 Where the level of risk transfer sought is equal to the min (α, β) Successful SRT will remove the protected tranches from the selling banks regulatory balance sheet, reducing RWEAs and saving the associated capital. Achieving SRT Given the CRR definition of mezzanine tranches it is unlikely that purchasing protection on just the VMT tranche in Transaction A would meet the quantitative tests set out in the CRR. Meaning that protection on the CS2 and S3 tranches would likely be necessary. Therefore, another important consideration in achieving SRT is implicit credit support. Taking the example of Transaction A, an issuer would likely need to protect both the CS2 and S3 tranches to achieve SRT, as if an issuer protected just the VMT and CS2 tranches while also having control over loan foreclosures and workouts etc. then the issuer could potentially provide credit support to CS2 investors by reassuming the risk in the S3 tranche. Therefore provided the transaction is properly structured it is possible to achieve regulatory capital relief alongside removing the P&L volatility created by IFRS 9 provisioning of a credit portfolio. The mechanics of the quantitative tests Subparagraph (2) of each of articles 243 and 244 outline what have come to be referred to by market participants as the quantitative tests, which if satisfied, are seemingly sufficient for firms to take the resulting capital relief. The tests essentially permit firms to take regulatory capital relief if they transfer the risk to an independent third party in relation to: At least 50% of the risk weighted exposure amounts (RWEA) of all mezzanine tranches in the securitisation, where mezzanine tranches are all tranches that are (a) not the most senior tranche and (b) subject to a risk weight of less than 1250% and are more junior to either (i) a Credit Quality Step (CQS) 1 rated tranche within the Standardised risk weight framework or (ii) a tranche rated either CQS 1 or CQS 2 under the Internal Ratings Based approach. Σ N RWEA i, Retained 50% i=1 i=1 For all (N) mezzanine tranches in the transaction Σ N RWEA i At least 80% of the exposure value of securitisation positions that are either 1250% risk weighted or would be subject to a deduction from Common Equity Tier 1, subject to, (a) there being no mezzanine positions in the transaction structure and (b) the exposure value of positions that would be either 1250% risk weighted or deducted from CET 1 substantially exceeds a reasonable estimate of the expected loss on the underlying assets. Σ N RWEA i, Retained 20% i=1 i=1 Σ N RWEA i It is possible to achieve regulatory capital relief alongside removing the P&L volatility created by IFRS 9. 3. CRR, June 2013 4. EBA Discussion Paper, September 2017 For all (N) tranches in the transaction that would be either 1250% risk weighted or subject to a deduction from CET 1. 4

Reducing leverage through accounting de-recognition The vast majority of post-crisis European securitisations have been on balance sheet for accounting purposes. This includes even those that have achieved some degree of significant risk transfer and which have been derecognised in part from the regulatory balance sheet. The potential benefit from achieving accounting de-recognition could be significant subject to the illustrated considerations around the determination of the leverage ratio. The path to accounting de-recognition Accounting de-recognition is linked principally to three factors, a) a qualifying transfer of cash flows, b) the transfer of risk and reward, and c) transfer of control. If, in a qualifying transfer, risk and reward substantially transfers to a third party then it is that third party which recognises the assets on its balance sheet. In practice transfer of 90% of the variability of returns to a third party is likely to result in a transfer of substantially all risks and rewards. At which point the transferor can derecognise the assets. In the case of a securitisation where only part of the structure such as a particular mezzanine tranche is protected for instance, this might create a situation whereby an entity has neither transferred nor retained substantially all of the variability of the returns, this leaves a question about how to recognise a partial transfer of risk and reward. The diagram below outlines four possible scenarios with regards to transfer of risk and reward. Continuing involvement In a situation whereby an entity has neither transferred nor retained substantially all of the risks and rewards, then de-recognition is required if the seller no longer controls the loans. However, this is often difficult to demonstrate for loan assets for which there is no active market and the buyer has the benefit of a risk sharing agreement with the seller. Accordingly, when control is retained, the continuing involvement approach should be applied. This results in the entity continuing to recognise an asset together with a new liability that, together, capture the rights and obligations retained rather than the whole portfolio. Therefore, in a SRT transaction where part of the risks and rewards have been transferred to a third party, but control retained, a seller is able to account for this under continuing involvement. While this isn t as advantageous as full off balance sheet treatment, partial de-recognition is still valuable, particularly in a world where banks are increasingly conscious of their leverage ratio. Upcoming changes to the definition of mezzanine tranches in the CRR From 1 January 2019 the CRR 5 will define mezzanine tranches as a position in the securitisation which is subordinated to the senior securitisation position and more senior than the first loss tranche, and which is subject to a risk weight lower than 1250 % and higher than 25 % The removal of CQS from the definition mezzanine will not only broaden the definition of mezzanine tranches but also broaden what qualifies as senior tranches. This will allow assets which could not achieve the necessary credit quality step to be used in transactions post 2018. The Spectrum of risk and reward Transferred substantially all Do not control assets Transferred some Control assets Retained substantially all Full de-recognition Full de-recognition Continuing involvement No de-recognition 5. CRR Amendment, REGULATION (EU) 2017/2401, December 2017 5

Next steps Impact of IFRS 9: Given the benign economic environment that IFRS 9 was introduced in, its effect on banks has been muted. However, when the economic cycle turns, IFRS 9 is expected to result in much earlier loan loss provisioning than IAS 39, creating the potential for P&L volatility. Mitigating IFRS 9 volatility: Securitisation provides a potential mechanism for mitigating the volatility, through transactions structured to transfer to investors the P&L volatility which occurs as a result of the movement of loan exposures from Stage 1 to Stage 2 and vice versa. The transaction outlined in the paper is one potential solution to achieve this. How Deloitte can help: We can support in a number of ways, these include, Working alongside firms who wish to execute transactions of this type Helping provide preliminary challenge to development of structural features, from both an investor and regulatory perspective Provide input to the technical accounting considerations of such transactions. Optimising the balance sheet: When considering a strategy to reduce the volatility from IFRS 9 provisioning, banks may wish to consider simultaneous opportunities to optimise their balance sheet. Along with the potential to mitigate IFRS 9 volatility, securitisation also provides scope to potentially reduce a) the risk weighted assets, and b) the leverage ratio of banks. Banks that are interested in these outcomes should be mobilising internally now in order to get ahead of their competitors. When considering a strategy to reduce the volatility from IFRS 9 provisioning, banks may wish to consider simultaneous opportunities to optimise their balance sheet. 6

Authors John Kent Partner +44 (0)20 7007 3748 jrkent@deloitte.co.uk David O Neill Senior Manager +44 (0)20 7007 1948 doneill@deloitte.co.uk Contacts Dan Keeble Partner +44 (0)20 7303 4461 dkeeble@deloitte.co.uk Simon Stephens Partner +44 (0)20 7303 2930 sstephens@deloitte.co.uk Other papers in the securitisation series CLO Structures An Evolution Securitisation: Risk Transferred or not? An Evolving European Landscape Securitisation Investor Due Diligence Demystified 7

This publication has been written in general terms and we recommend that you obtain professional advice before acting or refraining from action on any of the contents of this publication. Deloitte LLP accepts no liability for any loss occasioned to any person acting or refraining from action as a result of any material in this publication. Deloitte LLP is a limited liability partnership registered in England and Wales with registered number OC303675 and its registered office at 2 New Street Square, London EC4A 3BZ, United Kingdom. Deloitte LLP is the United Kingdom affiliate of Deloitte NWE LLP, a member firm of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ( DTTL ). DTTL and each of its member firms are legally separate and independent entities. DTTL and Deloitte NWE LLP do not provide services to clients. Please see www.deloitte.com/about to learn more about our global network of member firms. 2018 Deloitte LLP. All rights reserved. RITM188987